Abstract
Bullous pemphigoid (BP) is an autoimmune subepidermal blistering disease. In addition to autoantibodies, complement activation and inflammatory cells are necessary for lesion formation. In this study, we investigated the potential involvement of IL-1, secreted by various inflammatory and non-inflammatory cells, in BP lesions. We determined IL-1α IL-1β and IL-1 receptor antagonist in both blister fluid and concurrent serum samples of 10 BP patients by ELISAs. For comparison, we assayed experimentally generated suction blisters from 10 healthy volunteers. IL-1β levels were significantly elevated in BP blisters, whereas levels of IL-1α were decreased relative to those in controls. In concurrent serum samples, no IL-1α or IL-1β were detected in patients or controls. Levels of IL-1 receptor antagonist were significantly higher in BP blisters in relation to both concurrent sera and suction blisters. Our data indicate the release of IL-1β, IL-1 receptor antagonist, and to a lesser extent, of IL-1α, at the site of blister formation in BP and support the notion that cell-mediated immune mechanisms may contribute to blister formation in this disease.
| Original language | English |
|---|---|
| Journal | Journal of Dermatological Science |
| Volume | 11 |
| Issue number | 2 |
| Pages (from-to) | 142-147 |
| Number of pages | 6 |
| ISSN | 0923-1811 |
| DOIs | |
| Publication status | Published - 02.1996 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Research Areas and Centers
- Academic Focus: Center for Infection and Inflammation Research (ZIEL)
Fingerprint
Dive into the research topics of 'Detection of IL-1α, IL-1β and IL-1 receptor antagonist in blister fluid of bullous pemphigoid'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver